Article info
PDFExtended essay
Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
- Correspondence to Dr Nancy S Jecker, Department of Bioethics & Humanities, University of Washington, Seattle, WA 91895, USA; nsjecker{at}uw.edu
Citation
Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
Publication history
- Received October 31, 2020
- Revised January 17, 2021
- Accepted January 19, 2021
- First published February 16, 2021.
Online issue publication
May 07, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
- Love thy neighbour? Allocating vaccines in a world of competing obligations
- Vaccine equity in COVID-19: a meta-narrative review
- Justice in COVID-19 vaccine prioritisation: rethinking the approach
- Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies
- Considerations for vaccinating children against COVID-19
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Persons diagnosed with COVID-19 in England in the Clinical Practice Research Datalink (CPRD): a cohort description
- Towards a new model of global health justice: the case of COVID-19 vaccines
- Do coronavirus vaccine challenge trials have a distinctive generalisability problem?